Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
By intravenous or intramuscular injection under medical supervision
Semaglutide for the treatment of obesity
Understanding the differences can help you make an informed choice for your routine
Semaglutide (Ozempic, Wegovy, Rybelsus) : Available as once-weekly injection (0.52.0 mg for diabetes
Higher risk groups include: People starting GLP-1 medicines for the first time People whose dose is increased too quickly People who eat large, oily, or very sweet meals People with type 2 diabetes using insulin or sulfonylureas People with previous pancreatitis People with gallstones or gallbladder disease People with severe digestive disorders People with gastroparesis People with kidney disease People with dehydration risk People with diabetic retinopathy People with a personal or family history of medullary thyroid carcinoma People with Multiple Endocrine Neoplasia syndrome type 2 People with active mood disorders or suicidal thoughts People planning surgery or procedures under anaesthesia Patients With Diabetes Vs Non-Diabetic Users People with diabetes may use GLP-1 medicines to improve blood sugar control and support weight management
US$ 23.64
US$ 25.93
US$ 27.75
US$ 26.17
